Neurology News

Racial inequities in health care have fluctuated in severity for decades but data show that one constant remains: the disparities persist.

Neurona Therapeutics has announced that a phase 1/2 clinical trial for NRTX-1001, a regenerative neural cell therapy for treatment of drug-resistant focal epilepsy in adults, is now underway.

Mdoloris, a company specializing in medical pain monitoring technologies, announced its latest device, a bracelet that can record and track the pain and well-being of those who are unable to verbalize or indicate what they are feeling.

An 8-week course of true acupuncture reduced the monthly number of headache days in patients with chronic tension-type headache, with treatment effects lasting for 32 weeks, according to a study published in Neurology.

In children with epilepsy who discontinue anti-seizure medications, the risk for seizure relapse was significantly associated with younger age at diagnosis, according to a study published in Epilepsy & Behavior.

Men who experience behavioral changes, such as apathy or hallucinations, are at a faster risk for cognitive decline compared with women, findings published in the Journal of Alzheimer’s Disease showed.

In youth with Tourette syndrome and other persistent tic disorders, treatment with behavioral therapy was linked with symptom remission and a reduction in tic severity, according to a new study.

Biotechnology company bluebird bio announced that an FDA advisory committee has unanimously endorsed its gene therapy treatment for early active cerebral adrenoleukodystrophy.

CHARLOTTE, N.C. – Results from the Wake Up America poll showed that practitioners do not often ask patients about insomnia, and patients may be hesitant to discuss it, Andrew Krystal, MD, MS, said at the SLEEP meeting.

Treatment with tenecteplase in an Australian mobile stroke unit was safe and resulted in improved outcomes compared with alteplase, according to a study published in The Lancet Neurology.